In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: Formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1436, Issue 3, 1999, Pages 354-362

  Wang, Mei Mei ^a,b   Reynaud, Denis ^a   Pace Asciak, Cecil R ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

12(S) Hydroxy eicosatetraenoic acid; Bradykinin; Chirality; Epidermis; Formation; Hepoxilin; Platelet activating factor; Vascular permeability

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; BRADYKININ; HEPOXILIN A; HYDROXY FATTY ACID; LIPOXYGENASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD VESSEL PERMEABILITY; CHIRALITY; CONTROLLED STUDY; DOSE RESPONSE; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; 8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BRADYKININ; CAPILLARY PERMEABILITY; ENZYME ACTIVATION; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR; SKIN;

EID: 0345621688     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00128-3     Document Type: Article

References (48)

1. Majno G., Shea S., Leventhal M. J. Cell Biol. 42:1969;647-672.
2. Williams T., Morley J. Nature. 246:1973;215-217.
3. Bjork J., Hedqvist P., Arfors K.E. Inflammation. 6:1982;189-200.
4. Bray M.A., Cunnigham F.M., Ford-Hutchinson A.W., Smith M.J.H. Br. J. Pharmacol. 72:1981;483-486.
5. Chan C.C., Ford-Hutchinson A. J. Invest. Dermatol. 84:1985;154-157.
6. Erlansson M., Svensjö E., Bergqvist D. Inflammation. 13:1989;693-706.
7. Laneuville O., Corey E.J., Couture R., Pace-Asciak C.R. Eicosanoids. 4:1991;95-97.
8. Perlman M.B., Johnson A., Jubiz W., Malik A.B. Circ. Res. 64:1989;62-73.
9. Stenson W.F., Chang K., Williamson J.R. Prostaglandins. 32:1986;5-18.
10. Wang M.M., Demin P.M., Pace-Asciak C.R. Adv. Exp. Med. Biol. 416:1996;239-241.
11. Woodward D.F., Weichman B.M., Gill C.A., Wasserman M.A. Prostaglandins. 25:1983;131-142.
12. Demin P.M., Vasiljeva L.L., Belosludtsev Y.Y., Myagkova G.I., Pivnitsky K.K. Bioorg. Khim. 16:1990;571-572.
13. Demin P.M., Vasiljeva L.L., Myagkova G.I., Pivnitsky K.K. Bioorg. Khim. 17:1991;1133-1140.
14. P.M. Demin, C.R. Pace-Asciak, in: 207th ACS Meeting, San Diego, March 13-17, 1994, Abstract #120, MEDI.
15. Demin P., Reynaud D., Pace-Asciak C.R. J. Chromatogr. B. 672:1995;282-289.
16. Ruzicka T., Vitto A., Printz M. Biochim. Biophys. Acta. 751:1983;369-374.
17. Cameron G., Baldwin J., Jashway D., Patrick K., Fischer S. J. Invest. Dermatol. 94:1990;292-296.
18. Falgueyret J., Leblanc Y., Riendeau D. FEBS Lett. 262:1990;197-200.
19. von Zepelin H., Schroder J., Smid P., Reusch M., Christophers E. J. Invest. Dermatol. 97:1991;291-297.
20. Demin P., Reynaud D., Pace-Asciak C.R. Anal. Biochem. 226:1995;252-255.
21. O. Laneuville, E.J. Corey, C.R. Pace-Asciak, In: M. Bailey (Ed.), Prostaglandins, Leukotrienes, Lipoxins and PAF, XIth Washington International Spring Symposium, Plenum Press, New York, 1991, Abstract #155, pp. 335-338.
22. Ruzicka T., Aubock J. Adv. Prost. Thromb. Leuk. Res. 17:1987;657-663.
23. Kobza Black A., Barr R., Wong E., Brain S., Greaves M., Dickinson R., Shroot B., Hensby C. Br. J. Clin. Pharmacol. 20:1985;185-190.
24. Rosenbach T., Grabe J., Moller J., Schwanitz H., Czarnetski B. Br. J. Dermatol. 113:1985;157-167.
25. Rosenbach T., Czarnielewski B., Hecker M., Czarnetski B. J. Invest. Dermatol. 95:1990;104-105.
26. Ibe B., Falck J., Johnson A., Campbell W. Am. J. Physiol. 256:1989;C1168-C1175.
27. Legrand A., Lawson J., Meyrick B., Blair I., Oates J. J. Biol. Chem. 266:1991;7570-7577.
28. Salari H., Chan-Yeung M. Respir. Cell Mol. Biol. 1:1989;245-250.
29. Gesce A., Mezei Z., Telegdy G. Adv. Exp. Med. Biol. 198:1986;121-128.
30. Ziboh V., Lord J. Biochem. J. 184:1979;283-290.
31. Van den Bosch H. Biochim. Biophys. Acta. 604:1980;191-246.
32. Reynaud D., Demin P., Pace-Asciak C.R. J. Biol. Chem. 269:1994;23976-23980.
33. Pace-Asciak C.R., Lee W.-S. J. Biol. Chem. 264:1989;9310-9313.
34. Ikeda K., Tanaka K., Katori M. Prostaglandins. 10:1975;747-758.
35. Khalil Z., Helme R.D. Brain Res. 589:1992;102-108.
36. Fujii E., Irie K., Uchida Y., Ohba K., Muraki T. Eur. J. Pharmacol. 273:1995;267-272.
37. Turner S., Tainer J., Lynn W. Nature. 257:1975;680-681.
38. Goetzl E., Woods J., Gorman R.R. J. Clin. Invest. 59:1977;179-183.
39. Brigham K. Prog. Biochem. Pharmacol. 20:1980;26-37.
40. Okiji T., Morita I., Sunada I., Murota S. Arch. Oral Biol. 34:1989;523-528.
41. Reynaud D., Pace-Asciak C.R. Prostagl. Leuk. Essential Fatty Acids. 56:1997;9-12.
42. Nigam S., Nodes S., Cichon G., Corey E.J., Pace-Asciak C.R. Biochem. Biophys. Res. Commun. 171:1990;944-948.
43. Gross E., Ruzicka T., Mauch C., Krieg T. Prostaglandins. 36:1988;49-58.
44. Dowd P.M., Black A.K., Woollard P.M., Camp R.D.R., Greaves M.W. J. Invest. Dermatol. 84:1985;537-541.
45. Hein R., Gross E., Ruzicka T., Krieg T. Arch. Dermatol. Res. 28:1991;135-137.
46. Naccache P., Sha'afi R., Borgeat P., Goetzl E. J. Clin. Invest. 67:1981;1584-1587.
47. R. Anton, J. Abian, L. Vila, J. Mass Spectrom. Rapid Commun. Mass Spectrom. (1995) S169-S182.
48. Anton R., Puig L., Esgleyes T., Maria de Moragas J., Vila L. J. Invest. Dermatol. 110:1998;303-310.